Galectin Therapeutics (GALT) Reports Q2 Loss of $0.14/Share

Go back to Galectin Therapeutics (GALT) Reports Q2 Loss of $0.14/Share
GALECTIN (NASDAQ: GALT) Delayed: 3.46 -0.07 (1.98%)
Previous Close $3.53    52 Week High $3.05 
Open $3.50    52 Week Low $0.49 
Day High $3.55    P/E N/A 
Day Low $3.20    EPS $-1.32 
Volume 333,978